TransEnterix Agrees to Equity Offering Sales Deal with Cantor; Stock Down 2% Pre Bell

9:31AM ET 8/12/2019 MT Newswires
TransEnterix (TRXC), a medical device company, reported in a regulatory filing that it has entered into a controlled equity offering sales agreement with Cantor Fitzgerald to offer and sell up to $25 million of common stock at an assumed price of $1.05 a share, the closing rate from Friday.

Shares of TransEnterix were trading 2% lower in the pre-market session.

In accordance with the terms of the agreement, the company may offer and sell shares of common stock at any time and from time to time through or to Cantor as sales agent or principal.

Price: 1.0200, Change: -0.03, Percent Change: -2.86